First human test: can stem cells fight aging frailty?
NCT ID NCT07462819
Summary
This is an early safety study to see if a new stem cell therapy called Stemis™ is safe for older adults with mild to moderate frailty. About 12 participants, aged 60-85, will receive either the stem cell infusion or a placebo (saltwater) and be closely monitored for side effects. The main goal is to find a safe dose and check for any problems, while also exploring if it might improve walking, strength, or quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAILTY SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Taipei Medical University Hospital
Taipei, Taiwan
Conditions
Explore the condition pages connected to this study.